Personalized Vaccines, CAR-T, and AI: The New Horizon of Cancer Research 24/09/2025 Fundación Científica de la Asociación Española Contra el Cáncer Cancer research is advancing thanks to biotechnology, but it still faces challenges such as equitable access and the... AseBio - Fundación Científica de la Asociación Española Contra el Cáncer
Sepsis causes up to 20,000 annual deaths in Spain: Biotechnology is revolutionizing early ... 13/09/2025 Healthcare Personalized medicine Viva In Vitro, an AseBio member, has developed VIVA-ELISA, a biotechnology tool that rapidly detects activation of the... AseBio - VIVA IN VITRO
Sepsis causes up to 20,000 annual deaths in Spain: Biotechnology is revolutionizing early ... 13/09/2025 VIVA IN VITRO At a global scale, according to WHO data, between 48 and 50 million cases are estimated each year, with at least 11... AseBio - VIVA IN VITRO
New technology detects breast cancer relapse up to five years before symptoms appear using... 28/07/2025 Healthcare Personalized medicine A study led by Dr. Iñaki Comino-Méndez and Dr. Emilio Alba from the Hospital Universitario Virgen de la Victoria of... Partners - Altum Sequencing
World Multiple Sclerosis Day | “The integration of biotechnology and AI allows us to move ... 30/05/2025 Healthcare Personalized medicine Advanced therapies Interview with Mireia Forner, Medical Head of Neurology at Sanofi Iberia, a company working to change how multiple... AseBio - SANOFI
World Multiple Sclerosis Day | “The integration of biotechnology and AI allows us to move ... 30/05/2025 SANOFI Interview with Mireia Forner, Medical Head of Neurology at Sanofi Iberia, a company working to change how multiple... AseBio - SANOFI
Detecting the Undetectable: How Altum Sequencing Is Transforming Acute Myeloid Leukemia Mo... 29/05/2025 Healthcare Personalized medicine We demonstrated that our assay could detect residual disease in AML patients after treatment with 92% sensitivity and 88... Partners - Altum Sequencing
Nuage Therapeutics, Ona Therapeutics, and SpliceBio are leading the wave of biotech innova... 05/05/2025 Healthcare Rare diseases Personalized medicine Advanced therapies Las biotecnológicas Nuage Therapeutics, Ona Therapeutics y SpliceBio, con sede en el Parque Científico de Barcelona, han... Partners - Parc Científic de Barcelona
Biotechnology Advances in the development of key therapies for kidney diseases 13/03/2025 Healthcare Innovative drugs Personalized medicine Advanced therapies By 2040, chronic kidney disease (CKD) is projected to become the fifth leading cause of years of life lost, emphasizing... AseBio
Oryzon announces publication of study on Phelan-McDermid Syndrome (PMS) patients, a form o... 06/03/2025 Healthcare Access to innovation Personalized medicine Advanced therapies La revista Frontiers in Psychiatry publica un estudio que proporciona escalas clínicas y umbrales para la selección de... Partners - Oryzon Genomics
